
|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Participants
Advertisement
Articles in this issue
almost 29 years ago
Introduction: Looking Beyond the Formulary Budgetalmost 29 years ago
Evaluating the Cost Effectiveness of Newer Psychotropic Medicationsalmost 29 years ago
Looking Beyond the Formulary Budget in Cost-Benefit Analysisalmost 29 years ago
Retrospective Analysis of the Effect of Risperidone on Clinical Outcomealmost 29 years ago
Newer Antipsychotic Medications: Discussionsalmost 29 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Improving Patient-Centered Cardiovascular Care for Older Adults
3
Mitigate Treatment Burden in Heart Failure: Martha Gulati, MD
4
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
5
















































